Increasing Adoption Of Rising Focus on Personalized Medicine Fueling the Growth Of The Market Due To Increasing Demand For Tailored Preclinical Studies Is Influencing The In Vivo Contract Research Organization Market
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Will Be The Estimated Market Size Of The In Vivo Contract Research Organization Market By 2030?
The in vivo contract research organization market has experienced significant growth in its size over recent years. The market is anticipated to expand from $5.23 billion in 2025 to $5.68 billion in 2026, at a compound annual growth rate (CAGR) of 8.6%. Historically, this expansion has been driven by increased spending on pharmaceutical research and development, the growth in biotechnology pipelines, the escalating complexity of drug development processes, more rigorous regulatory mandates for preclinical data, and the accessibility of advanced animal models.
The in vivo contract research organization market size is poised for substantial growth over the next few years, with projections indicating an increase to $7.77 billion by 2030, achieving a compound annual growth rate (CAGR) of 8.1%. This expansion during the forecast period can be primarily linked to several factors: a heightened urgency for quicker drug development timelines, the increased adoption of advanced in vivo disease models, the broader scope of research into oncology and rare diseases, the growing integration of AI-enabled preclinical analytics, and more rigorous regulatory examination of safety data. Significant trends anticipated during this period include a greater reliance on outsourcing for preclinical research activities, a rising necessity for specialized disease models, the broader implementation of GLP-compliant toxicology studies, an expansion of comprehensive preclinical service offerings, and a sharpened focus on data integrity and reproducibility.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25790&type=smp
What Primary Factors Are Fueling The Expansion Of The In Vivo Contract Research Organization Market?
The expansion of the in vivo contract research organization market is anticipated to be fueled by the increasing emphasis on personalized medicine. This medical approach customizes treatment and prevention strategies for individuals based on their genetic profile, lifestyle, and environmental factors, aiming to improve health outcomes. The heightened attention to personalized medicine stems from the enhanced accessibility and reduced cost of genomic sequencing technologies, which facilitate a more precise identification of genetic mutations, leading to the development of specific therapies that enhance patient results and minimize inefficient treatment trials. Consequently, this increasing focus on personalized medicine is boosting demand within the in vivo CRO market, necessitating tailored preclinical studies utilizing particular animal models to assess targeted therapies and their impact on unique genetic profiles. For example, data from February 2024, provided by the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, indicated that the FDA sanctioned 16 new personalized treatments in 2023, marking an increase from six in 2022. Furthermore, personalized medicines constituted more than one-third of all novel drug approvals by the U.S. Food and Drug Administration (FDA) for the fourth consecutive year. This sustained emphasis on personalized medicine is, therefore, accelerating the expansion of the in vivo contract research organization market.
What Are The Core Segment Classifications In The In Vivo Contract Research Organization Market?
The in vivo contract research organization market covered in this report is segmented –
1) By Type: Rodent Based, Non-Rodent Based
2) By Type Of Service: Translational And IND-Enabling In Vivo Studies, Preclinical Services, Post-Approval Nonclinical Safety And Mechanistic Studies
3) By Good Laboratory Practice Type: Good Laboratory Practice Toxicology, Non Good Laboratory Practice
4) By Applications: Oncology, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Other Applications
5) By End User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Government And Regulatory Bodies
Subsegments:
1) By Rodent-Based: Mice Models, Rat Models, Genetically Engineered Rodents, Immunodeficient Rodents, Humanized Rodents
2) By Non-Rodent-Based: Canine Models, Non-Human Primate Models, Swine Models, Rabbit Models, Zebrafish Models
Which Trends Are Influencing The Expansion Of The In Vivo Contract Research Organization Market?
Leading companies within the in vivo contract research organization market are focusing on creating novel solutions, such as advanced therapy incubator programs, to accelerate the progression of next-generation therapeutics and support initial clinical research. An advanced therapy incubator program serves as a specialized initiative crafted to assist early-stage biotechnology enterprises by providing essential resources, mentorship, and infrastructure, thereby accelerating the development of advanced therapies, including gene, cell, and RNA-based treatments. For instance, in April 2025, Charles River Laboratories International Inc., a US-based pharmaceutical company, introduced its inaugural advanced therapy incubator program cohort. This innovative program aims to support nascent biotech companies dedicated to developing future therapies. Through this initiative, participants gain access to Charles River’s scientific proficiency, advanced laboratory facilities, and customized in vivo models, enabling them to swiftly generate proof-of-concept data. The program further provides a realistic preclinical setting for validating therapeutic candidates, helping to shorten the timeline to clinical trials and enhance the prospects of regulatory approval. By connecting academic breakthroughs with clinical progression, this initiative plays a vital role in advancing the field of advanced therapies.
Who Are The Leading Firms Participating In The In Vivo Contract Research Organization Market?
Major companies operating in the in vivo contract research organization market are Thermo Fisher Scientific Inc, Labcorp Drug Development Inc, Eurofins Scientific SE, WuXi AppTec, Charles River Laboratories International Inc, Evotec SE, GemPharmatech Co Ltd, BIOQUAL Inc, Crown Bioscience Inc, PsychoGenics Inc, Janvier Labs SAS, Taconic Bioscience Inc, Xentech SAS, Altogen Labs Inc, AniLocus Inc, Pharmaron Beijing Co Ltd, Southern Research Institute, SRI International, Envigo RMS LLC, Horizon Discovery Group plc, Inotiv Inc, GenScript ProBio
Access The Complete In Vivo Contract Research Organization Market Report:
Which Region Stands As The Largest Contributor To The In Vivo Contract Research Organization Market?
North America was the largest region in the in vivo contract research organization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo contract research organization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access In Vivo Contract Research Organization Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=25790&type=smp
Browse Through More Reports Similar to the Global In Vivo Contract Research Organization Market 2026, By The Business Research Company
Biologics Contract Development Global Market Report 2026
Medical Device Contract Manufacturing Global Market Report 2026
Contract Development Manufacturing Organizations Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
